FWP
IHE icon

FAS Wealth Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

FAS Wealth Partners’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-867
Closed -$53K – 412
2021
Q3 		$53K Hold
867
– – 0.01% 332
2021
Q2 		$54K Sell
867
-603
-41% -$36.7K 0.01% 318
2021
Q1 		$87K Hold
1,470
– – 0.01% 285
2020
Q4 		$88K Buy
+1,470
New +$83.8K 0.01% 279

Other funds holding IHE

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

FAS Wealth Partners's IHE Position: Q4 2021 in Review

FAS Wealth Partners sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2021, closing a stake of 867 shares — an estimated $53K sold.

FAS Wealth Partners first reported a position in IHE in Q4 2020 and held it in 4 quarters. The position peaked at $88K in Q4 2020. 112 funds tracked by Wall St. Rank hold IHE as of Q4 2021.

  • FAS Wealth Partners reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
  • FAS Wealth Partners sold 867 iShares US Pharmaceuticals ETF shares in Q4 2021, an estimated $53K.
  • FAS Wealth Partners first reported a position in iShares US Pharmaceuticals ETF in Q4 2020 and held it in 4 quarters.
  • FAS Wealth Partners's iShares US Pharmaceuticals ETF position peaked at $88K in Q4 2020.
  • 112 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2021.

Based on FAS Wealth Partners's 13F filing for Q4 2021, filed 11 Feb 2022.